Author(s): Johnston, S Claiborne MD, PhD; Dowd, Christopher F. MD; Higashida, Randall T. MD; Lawton, Michael T. MD; Duckwiler, Gary R. MD; Gress, Daryl.

Slides:



Advertisements
Similar presentations
Agency for Healthcare Research and Quality (AHRQ)
Advertisements

Aneurysmal Subarachnoid Hemorrhage
Long Term Follow-Up After Imatinib Cessation for Patients in Deep Molecular Response: The Update Results of the STIM1 Study1 Preliminary Report of the.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study Lancet.
STROKE Dr Ubaid N P Community Medicine Pariyaram Medical College.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Open Repair of Ruptured Descending Thoracic and Thoracoabdominal Aortic Aneurysms in 100 Consecutive Cases Mario F. Gaudino, Christopher Lau, Monica Munjal,
Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Study Design. Study Designs Descriptive Studies Record events, observations or activities,documentaries No comparison group or intervention Describe.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
1 Statin treatment is associated with improved prognosis in patients with AF-related stroke G. Ntaios, V. Papavasileiou, K.Makaritsis, A.Karagiannaki,
Clinical Trial Results. org Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD, Leslee J. Shaw, PhD, Sandy T. Liu, Steven.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Monthly Journal article review: Vimmi Kang PGY 2
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Neuro Labs and Best Practices in Stroke Programs Sarah L. Livesay, DNP, RN, ACNP-BC Associate Professor Rush University College of Nursing.
Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
PJ Devereaux, Population Health Research Institute, Hamilton, Canada on behalf of POISE-2 Investigators PeriOperative ISchemic Evaluation-2 Trial POISE-2POISE-2.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Long-Term Comparison of Medical Treatment With Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism: A Propensity-Score.
INTRODUCTION Emotional distress and sense of burden are experienced by many caregivers of persons with traumatic brain injury (TBI). 1-8 Predicting which.
Charles Henderson. Purpose To occlude the aneurysm sac in an attempt to preserve the parent artery. A brain aneurysm, also called a cerebral or intracranial.
Safety of Cerebral Digital Subtraction Angiography in Pediatric Patients with Sickle Cell Disease. Emily Wyse, BS 1 Jessica Carpenter, MD 2 Suresh Magge,
Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.
Aneurysmal Rupture during Embolization with Guglielmi Detachable Coils: Causes, Management and Outcome Dae Hyun Hwang M.D.,PhD.,YoungHwan Ko M.D., Kook.
H.Ghanaati; M.D. Associate Professor of Radiology Tehran University Of Medical Sciences Outcomes of intracranial aneurysms treated with coils: A six-month.
XIX Symposium Neuroradiologicum Bologna,Italy 4-9 october 2010 Endovascular treatment of 50 posterior communicating artery aneurysms: overall, perioperative.
EBM --- Journal Reading Presenter :林禹君 Date : 2005/10/26.
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal.
Traumatic arterial injuries: endovascular treatment Martha A. Quiodettis May 25, 2010.
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
O Mansour, J Weber and M Schumacher Neuroradiology Depart. Freiburg Univ. Neurology Depart. Alexandria Univ. Department of Neuroradiology, Neurocenter.
Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention Lisette Okkels Jensen,
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial 颈动脉内膜切除术无症状狭窄 多中心随机试验.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Three-Year Outcome of Endovascular Treatment of Superficial.
Presentation: eP-26. There is no conflict of interest in this presentation.
Clinical predictors of delayed cerebral ischemia after subarachnoid hemorrhage: First experience with coil embolization in the management of ruptured cerebral.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Preoperative Anemia and Postoperative Mortality in Neonates Goobie SM, Faraoni D,
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
Endovascular Surgical Neuroradiology
Endovascular treatment of intra- and extra cranial malformation
Total Occlusion Study of Canada (TOSCA-2) Trial
UOG Journal Club: April 2016
Prediction and Prevention of Stroke in Patients with Symptomatic Carotid Stenosis: The High-risk Period and the High-risk Patient  P.M. Rothwell  European.
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Description: The goal of the trial was to assess.
Cerebral aneurysm-single center experience
Women, Bleeding, and Coronary Intervention
Risk of Stroke or Death Is Associated With the Timing of Carotid Artery Stenting for Symptomatic Carotid Stenosis: A Secondary Data Analysis of the German.
IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis  Donald.
Baseline characteristics of HPS participants by prior diabetes
Management of unruptured intracranial aneurysm
Monthly Journal article review: Vimmi Kang PGY 2
Defining risk and identifying predictors of mortality for open conversion after endovascular aortic aneurysm repair  Salvatore T. Scali, MD, Adam W. Beck,
M Javanbakht, S Guerry, LV Smith, P Kerndt
Atlantic Cardiovascular Patient Outcomes Research Team
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial  Scott A. Berceli, MD,
Presentation transcript:

Author(s): Johnston, S Claiborne MD, PhD; Dowd, Christopher F. MD; Higashida, Randall T. MD; Lawton, Michael T. MD; Duckwiler, Gary R. MD; Gress, Daryl R. MD; for the CARAT Investigators. Issue: Stroke, Volume 39(1), January 2008, pp Publisher:© 2008 American Heart Association, Inc.

Introduction

-The primary purpose of intracranial aneurysm treatment is to prevent rupture. - Risk factors for rupture after aneurysm treatment have not been clearly established, and the need to completely occlude aneurysms is debated. - Delayed rerupture is rare after a ruptured intracranial aneurysm is treated with either coil embolization or surgical clipping. - Early rerupture of treated aneurysms occurs more frequently and has major consequences. -The primary purpose of intracranial aneurysm treatment is to prevent rupture. - Risk factors for rupture after aneurysm treatment have not been clearly established, and the need to completely occlude aneurysms is debated. - Delayed rerupture is rare after a ruptured intracranial aneurysm is treated with either coil embolization or surgical clipping. - Early rerupture of treated aneurysms occurs more frequently and has major consequences.

- In the Cerebral Aneurysm Rerupture After Treatment (CARAT) study, the overall risk of rerupture in the first year after treatment is 1.8%. - Similarly, the International Subarachnoid Aneurysm Treatment (ISAT) found a 1.7% risk of rerupture in the first year. - Predictors of rerupture after aneurysm treatment have not been carefully studied. As most of these studies have generally not been controlled and follow-up has been variable. - This study sought to identify risk factors for rerupture after treatment of intracranial aneurysms, paying particular attention to degree of aneurysm occlusion, using data from CARAT, - In the Cerebral Aneurysm Rerupture After Treatment (CARAT) study, the overall risk of rerupture in the first year after treatment is 1.8%. - Similarly, the International Subarachnoid Aneurysm Treatment (ISAT) found a 1.7% risk of rerupture in the first year. - Predictors of rerupture after aneurysm treatment have not been carefully studied. As most of these studies have generally not been controlled and follow-up has been variable. - This study sought to identify risk factors for rerupture after treatment of intracranial aneurysms, paying particular attention to degree of aneurysm occlusion, using data from CARAT,

Methods

The Cerebral Aneurysm Rerupture After Treatment (CARAT) study An ambidirectional cohort study of 1010 patients treated with coil embolization or surgical clipping. Patients were treated at 9 hospitals in 8 high-volume centers in the United States from1st of Jan 1996 to end of December Patients were followed for up to 9 years to determine whether delayed rerupture of treated aneurysms. Inclusion criteria: subarachnoid hemorrhage due to rupture of a saccular intracranial aneurysm and a coil or clip was deployed in an attempt to treat the index aneurysm.

Exclusion criteria: - Patients were younger than 18 years at follow-up. - An intracranial arteriovenous malformation or fistula was present. - Vessel occlusion was used to treat the aneurysm. - An endovascular balloon was used for embolization. - The patient did not have a US Social Security number. - Those without information on degree of aneurysm occlusion after treatment (n=9).

- Any aneurysm considered a possible source of the initial subarachnoid hemorrhage and treated during the first procedure was defined as an index aneurysm. - For coiled patients, postprocedural angiography was the source of the Degree of aneurysm occlusion. - For clipped patients, angiography was used when available; otherwise, the operative report was used. - The following scheme was used to convert descriptive terms to categories of occlusion: Complete occlusion, 100% Small residual neck, 91% to 99% Residual neck, 70% to 90% Partial occlusion (residual aneurysm), 1% to 69% Not occluded, 0%

Results

-Overall, of 1001 included patients index aneurysms were: completely occluded after the first intervention in 760 (75.9%) 91% to 99% occluded in 173 (17.3%) 70% to 90% occluded in 51 (5.1%) <70% occluded in 17 (1.7%) - Rates of total occlusion were greater in patients treated with clipping (646 of 706, 92%) than with coiling (114 of 295, 39%; P<0.0001). - Patients with complete aneurysm occlusion (compared with those with partial aneurysm occlusion) were: younger less likely to have chronic obstructive pulmonary disease, less likely to have posterior circulation aneurysms.

-During a mean of 3.6 years follow-up (median 4.4 years, range 0 to 9.6 years), there were 19 nonprocedural reruptures (overall risk ignoring loss to follow-up, 1.9%). - The median time to rerupture was 3 days (range 1 day to 1.1 year). In Kaplan–Meier analysis, the risk of rupture was 2.2% in the first year, 0.2% in the second year, and 0% thereafter. - Rerupture resulted in death within 1 month in 58% of reruptures. - The degree of aneurysm occlusion after treatment was strongly associated with risk of rerupture, cumulative risk was: 1.1% for complete occlusion, 2.9% for 91% to 99% occlusion, 5.9% for 70% to 90%, 17.6% for <70%; P< by log-rank test

- Overall, 17 of 19 reruptures occurred in the first month after treatment. - Among those with rerupture, degree of aneurysm occlusion was not associated with risk of death (P=0.22). - Risk of rerupture tended to be greater after coil embolization compared with surgical clipping, However, the difference was not significant (hazard ratio, 1.09; 95% CI, 0.32 to 3.69; P=0.89). - A history of peripheral vascular disease was the only other patient or aneurysm characteristic that independently predicted rerupture - There were no reruptures after retreatment. - The association between degree of aneurysm occlusion remained a strong predictor of risk of rerupture in an analysis without censoring at time of retreatment (P<0.001).

- There was no evidence that attempting more complete aneurysm occlusion was associated with a greater risk of complications in the index procedure. Specifically, among those treated with clipping. - There was no association with degree of occlusion and either perioperative disability/mortality (P=0.31) or intraprocedural rupture (P=0.77). - For those treated with coiling results of degree of occlusion and risk of intraprocedural rupture were similar (P=0.38). - there was an insignificant trend toward greater risk of new disability with greater degrees of occlusion achieved during the index treatment (P=0.07

Discussion

-This study found that early rerupture was an infrequent but important early complication of treatment, particularly among those treated with coil embolization. - Half of reruptures occurred during the first 3 days after treatment. - Incomplete occlusion of the aneurysm was a strong predictor of risk of rerupture. - The risk of rupture in aneurysms that were <70% occluded was 24.5% in the first year, similar to rerupture rates in prior studies of untreated ruptured aneur ysms. - There is no evidence to suggest that attempting complete occlusion was associated with increased procedural risk -This study found that early rerupture was an infrequent but important early complication of treatment, particularly among those treated with coil embolization. - Half of reruptures occurred during the first 3 days after treatment. - Incomplete occlusion of the aneurysm was a strong predictor of risk of rerupture. - The risk of rupture in aneurysms that were <70% occluded was 24.5% in the first year, similar to rerupture rates in prior studies of untreated ruptured aneur ysms. - There is no evidence to suggest that attempting complete occlusion was associated with increased procedural risk

-Complete aneurysm occlusion after initial treatment did not guarantee that rerupture would not occur, though the risk of rerupture was only 1.1% in this group with all events occurring during the first year. - Follow-up imaging in all patients with treated aneurysms is very important, particularly during the first year after initial treatment. - The risk of rerupture and the inconvenience and risk of retreatment should be considered when consenting patients for treatment. - Eighteen of the 19 reruptures in this study occurred during the first year after treatment, with half occurring during the first 3 days. - After 1 year, the annual risk of rerupture was 0.11% in patients treated with coil embolization, and there were no reruptures among clipped patients.

-The most obvious limitation of this study is the lack of standardization in assessment of degree of aneurysm occlusion. - Although angiography was routine immediately after coil embolization, it was performed only in a subset of patients after clipping, and degree of occlusion was derived from operative reports in these instances. - Though this was a large study, the actual number of patients with rerupture was small, thus limiting the power of the study, this may have impacted the ability to identify other factors associated with rerupture, including larger aneurysm size, which has been associated with risk of rerupture before treatment - On the other hand, the study evaluated multiple factors as potential confounders, so the association of aneurysm rerupture with peripheral vascular disease could have been due to chance and requires independent confirmation.

Conclusions:- Degree of aneurysm occlusion after the initial treatment is a strong predictor of the risk of subsequent rupture in patients presenting with subarachnoid hemorrhage, which justifies attempts to completely occlude aneurysms.